[Federal Register Volume 64, Number 115 (Wednesday, June 16, 1999)]
[Notices]
[Page 32246]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 99-15236]



[[Page 32246]]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute on Drug Abuse; Notice of Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute on Drug Abuse Special 
Emphasis Panel Prevention Services Research Replicating a School-
Based Program.
    Date: July 28, 1999.
    Time: 1 PM to 5 PM.
    Agenda: To review and evaluate grant applications.
    Place: Neuroscience Center, National Institutes of Health, 6001 
Executive Blvd., Bethesda, MD 20892.
    Contact Person: William C. Grace, PHD., Deputy Director, Office 
of Extramural Program Review, National Institute on Drug Abuse, 
National Institutes of Health, DHHS, 6001 Executive Boulevard, Room 
3158, MSC 9547, Bethesda, MD 20892-9547, (301) 443-2755.

(Catalogue of Federal Domestic Assistance Program Nos. 93.277, Drug 
Abuse Scientist Development Award for Clinicians, Scientist 
Development Awards, and Research Scientist Awards; 93. 278, Drug 
Abuse National Research Service Awards for Research Training; 
93.279, Drug Abuse Research Programs, National Institutes of Health, 
HHS)

    Dated: June 9, 1999.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory Committee Policy, National 
Institute of Health.
[FR Doc. 99-15236 Filed 6-15-99; 8:45 am]
BILLING CODE 4140-01-M